Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Annals of Oncology Impact Factor

NEW! Impact Factor: 50.5

Editor in Chief: Thomas Powles – view the full editorial board

Annals of Oncology Aims and Scope

  • Annals of Oncology is a multidisciplinary journal publishing articles addressing medical oncology in particular, but also surgery, radiotherapy, paediatric oncology, basic research and the comprehensive management of patients with malignant diseases.   
  • Annals of Oncology has a global readership: 900,000 unique visitors per year from 213 countries via its ScienceDirect platform (2022).
  • Annals of Oncology can be accessed through OncologyPRO, ESMO’s scientific and educational oncology portal – part of the World Oncology Literature Service giving access to search the most relevant oncology journals worldwide
  • Annals of Oncology meets the fast changing needs of ESMO members and the medical oncology community at large and is a global leader among clinical oncology journals.
  • Annals of Oncology is also the official journal of the Japanese Society of Medical Oncology (JSMO)
  • Annals of Oncology has a mobile-optimised site.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.